Dr. Chari Cohen, president of the Hepatitis B Foundation, says recently proposed guidance to scale back routine newborn hepatitis B vaccinations has no scientific justification. She warns that reducing or delaying the birth dose could undermine decades of progress in preventing perinatal transmission and protecting infants. The Foundation is urging policymakers and clinicians to maintain evidence-based newborn vaccination practices to preserve hard-won gains against hepatitis B.
